Home  |  Contact Us  
Healthcare Venture Capital and Growth Equity     
Home About Us Our Focus Our Team Portfolio Companies Media Center Limited Partners Contact Us
 
 Portfolio Companies
  Accumetrics
  Alereon
  Apollo Endosurgery
  Asuragen
  BioForm
  BioMimetic
  BioSET
  Cameron Health
  Cardiva Medical
  GlycoMimetics
  IDEV Technologies
  InSite Vision
  Intersect ENT
  LDR Spine
  Mirna Therapeutics
  On-X Life Technologies
  Ortho Kinematics
  OsteoBiologics
  Tryton Medical
  ZIOPHARM Oncology
 
 News and Press
PTV Sciences Announces Three New Venture Partners, Serving as Senior Advisors; Dennis Donohoe, M.D., Marlene Wright Valenti, and Dan Walsh
Julio Palmaz, M.D., Inventor of the World's First Cardiac Stent, is the 2009 Recipient of the PTV Sciences Star of Texas Healthcare Award
Mark McClellan, M.P.A., M.D., Ph.D., Former Commissioner of the Food and Drug Administration, will Serve As Honorary Chair and Keynote Speaker at the PTV Sciences Annual Meeting



Accumetrics, Inc.

Accumetrics, Inc. Forms Partnership with Grifols as Its Distributor in Spain, Portugal and Chile

Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled

Accumetrics, Inc. Announces Distribution Channels in Israel and Cyprus

back to top

Alereon, Inc.

Ultrawideband: Down, But Far From Out

WiMedia and UWB: where to from here?

Alereon Receives FCC Modular Certification for Worldwide Wireless USB Half-MiniCard   

back to top

Apollo Endosurgery, Inc.

Three Austin Companies Get Cancer Research Grants

Most Successful U.S. Startups 2008: Apollo Endosurgery - BusinessWeek

Apollo Endosurgery Announces 510(k) Clearance for its Flexible Endoscopic Suturing System

Surgery Without the Slicing

back to top

Asuragen, Inc.

Asuragen's Ground Breaking Research Funded with Help from Grants Program

Asuragen Appoints French Distributor Biomedical Diagnostics SA for Signature Oncology Portfolio

Mirna Therapeutics Announces Dr. Frank Slack as Scientific Advisor

Gov. Perry Announces $5 Million Investment in Development, Commercialization of Cancer Treatment

back to top

BioForm Medical, Inc. (NASDAQ: BFRM)
Merz to Acquire BioForm Medical

BioForm Medical Strengthens Its Board of Directors With Three Aesthetics Industry Veterans

BioForm Medical to Launch New 1.5cc RADIESSE(r) Volume Advantage Syringe and 0.8cc RADIESSE Moderate Fill Syringe; Announces Successful Results of RADIESSE Dermal Filler With Lidocaine Clinical Study

back to top

BioMimetic Pharmaceuticals, Inc. ("BMTI") (NASDAQ: BMTI)

BioMimetic nears European patent on tissue healing products

Dr. Samuel E. Lynch Presides Over the NASDAQ Closing Bell to Celebrate the Initial Public Offering of BioMimetic Therapeutics, Inc. [BMTI]

back to top

BioSurface Engineering Technologies, Inc. ("BioSET")
Brookhaven Lab and BioSET, Inc., Patent a Synthetic Peptide That Enhances Bone Growth

BioSET Announces Initiation Of Clinical Trials For AMPLEX Osteo-Promotive Bone Graft System For Spine Fusion

Tornier and Bioset Enter Synthetic Growth Factor Pact

back to top

Cameron Health, Inc.
Entirely Subcutaneous ICD Eliminates Need For Transvenous Lead Wires

The rhythm of life

Cameron Health Commences Clinical Trial of the Minimally Invasive Totally Subcutaneous Implantable Defibrillator for Treatment of Sudden Cardiac Arrest

back to top

Cardiva Medical, Inc.
Cardiva Medical, Inc. Announces Appointment of Charles Maroney, President and Chief Executive Officer

Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst III System

Cardiva Medical, Inc. Announces Presentation at the 2008 UBS Global Life Science Conference

back to top

GlycoMimetics, Inc. ("GMI")
GlycoMimetics, Inc. Attracts $38 Million in Latest Venture Round

New Drug to Treat Sickle Cell Crisis Begins Pilot Study in Patients

GlycoMimetics, Inc. Awarded NIH Grant to Study Drug Candidate in Diabetes

GlycoMimetics, Inc. Completes Phase 1 Clinical  Studies of Lead Drug Candidate

back to top

IDEV Technologies, Inc.
IDEV Technologies Names Veteran Healthcare Executive Dennis Donohoe, M.D. Chief Medical Officer

IDEV Technologies  Introduces SUPERA VERITAS™ Stent Delivery System in Europe

IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer

IDEV Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA Peripheral Stent

back to top

InSite Vision, Inc. ("ISV") (INSV.OB)
InSite Vision Signs International Licensing and Distribution Agreement for AzaSite((R)) in Japan and Taiwan With Nitten Pharmaceutical Co., Ltd

InSite Vision Receives Regulatory Approval for AzaSite® in Canada

InSite Vision Announces Restructuring to Support 2009 Strategic Priorities

back to top

Intersect ENT, Inc. (formerly Sinexus)
Sinexus Changes Name to Intersect ENT, Initiates Pivotal Study

back to top
LDR Spine USA, Inc. ("LDR")
1st Mobi-C® cervical artificial disc implanted in China

LDR Announces FDA Clearance of its ROI-A™ ALIF Device

LDR opens direct sales channel in Germany

back to top

Mirna Therpeutics, Inc.
Mirna Therapeutics recommended for $10 million commercialization award from the Cancer Prevention and Research Institute of Texas

back to top

On-X® Life Technologies, Inc.
On-X Life Technologies Doubles Manufacturing Space in Austin

Examination of hemolytic potential with the On-X(R) prosthetic heart valve

Austin-Based Medical Carbon Research Institute, LLC. Becomes On-X Life Technologies, Inc.

back to top

Ortho Kinematics, Inc.
Kinegraph VMA™ (Vertebral Motion Analyzer) Video

Gov. Perry: We Must Invest Wisely to Help Texans and Strengthen Our Economy

back to top

OsteoBiologics, Inc. ("OBI") - Acquired by: Smith & Nephew
Smith & Nephew Acquires OBI, Inc.

back to top
Tryton Medical, Inc.
TRYTON Announces Registry Evaluating Tryton Stent System for Left Main Disease and Celebrates 500th Implant

Tryton Celebrates 250th Implant of Innovative Side Branch Stent System

Tryton Announces First Patient Enrollment in E-Tryton 150 Registry

Tryton Medical introduces Side Branch Stent System in Europe

back to top

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP)
ZIOPHARM Presents Positive Darinaparsin Clinical Data at ASCO's Prestigious Clinical Science Symposium

ZIOPHARM Presents Positive Data from Phase I Study of Palifosfamide in Combination with Doxorubicin at ASCO

ZIOPHARM Presents Positive Indibulin Translationaland Dose Scheduling Data at ASCO

back to top

 
 
 

 

Home | Site Map | Contact Us
            All rights reserved 2008 PTV Sciences